<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Overexpressed DNA methyltransferase 1 (DNMT1) strongly contributes to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene silencing in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, the underlying mechanism of DNMT1 overexpression is still unclear </plain></SENT>
<SENT sid="2" pm="."><plain>MicroRNAs (miRNA) have been implicated as gene regulators controlling diverse biological processes, including <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we investigated whether some miRNA is involved in the regulation of DNMT1 and thus play a functional role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Our results showed that miR-342 was downregulated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues and cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>Restoration of miR-342 resulted in a dramatic reduction of the expression of DNMT1 at both <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> and protein levels by directly targeting its 3' untranslated region </plain></SENT>
<SENT sid="6" pm="."><plain>This in turn reactivated ADAM23, Hint1, RASSF1A and RECK genes via promoter demethylation </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the enhanced expression of miR-342 could significantly inhibit SW480 cell proliferation in vitro (P = 0.006) </plain></SENT>
<SENT sid="8" pm="."><plain>Further investigation demonstrated G(0)/G(1) cell cycle arrest in SW480 cells, which was associated with an upregulation of p21 and downregulation of cyclinE and CDK2 </plain></SENT>
<SENT sid="9" pm="."><plain>Overexpression of miR-342 also inhibited SW480 cell invasion </plain></SENT>
<SENT sid="10" pm="."><plain>The in vivo antitumor effect was evaluated in SW480 cells with lentivirus-mediated expression of miR-342 </plain></SENT>
<SENT sid="11" pm="."><plain>Results showed that overexpression of miR-342 significantly inhibited <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice (P = 0.034) </plain></SENT>
<SENT sid="12" pm="."><plain>Our findings describe a new mechanism for the regulation of DNMT1 and aberrant DNA hypermethylation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>This is also the first report to demonstrate that miR-342 may act as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development </plain></SENT>
<SENT sid="14" pm="."><plain>The newly identified miR-342/DNMT1 link provides a new, potential therapeutic target for the treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>